{
    "nct_id": "NCT05212272",
    "official_title": "A Feasibility Study of Interim PET-MRI in High-grade Glioma Patients Undergoing Chemoradiation",
    "inclusion_criteria": "* Pathologically confirmed diagnosis of high grade glioma (grade III or IV) or WHO grade II glioma, IDH wildtype (molecular glioblastoma multiforme [GBM]).\n* â‰¥18 years of age.\n* ECOG performance status of 0 to 3\n* Anticipated to receive 6 weeks of chemoradiation\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Does not speak or read English\n* Unable to participate in cognitive testing due to aphasia or other severe cognitive impairment as determined by the PI, or Dr. Cummings or her designee.\n* Unable to give informed consent\n* Past medical history of any kind of dementia or diagnosed with mild cognitive impairment prior to diagnosis with their brain tumor\n* Unable to safely fast for 8 hours prior to bloodwork or 6 hours prior to PET scan\n* Currently taking cognition-enhancing medications including:\n\n  * Donepezil\n  * Memantine\n  * Armodafinil\n  * Methylphenidate\n* Pregnant or nursing mothers.\n* Patients taking blood thinners will be excluded from the optional Lumbar Puncture only, they are eligible for participation in the main study-provided they meet inclusion/exclusion criteria",
    "miscellaneous_criteria": ""
}